These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38266062)
1. Comprehensive analysis of clinical and biological features in Parkinson's disease associated with the LRRK2 G2019S mutation: Data from the PPMI study. Sun X; Dou K; Xue L; Xie Y; Yang Y; Xie A Clin Transl Sci; 2024 Jan; 17(1):e13720. PubMed ID: 38266062 [TBL] [Abstract][Full Text] [Related]
2. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K; Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032 [TBL] [Abstract][Full Text] [Related]
3. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study. Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881 [TBL] [Abstract][Full Text] [Related]
4. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study. Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725 [TBL] [Abstract][Full Text] [Related]
12. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. Ortega RA; Wang C; Raymond D; Bryant N; Scherzer CR; Thaler A; Alcalay RN; West AB; Mirelman A; Kuras Y; Marder KS; Giladi N; Ozelius LJ; Bressman SB; Saunders-Pullman R JAMA Netw Open; 2021 Apr; 4(4):e215845. PubMed ID: 33881531 [TBL] [Abstract][Full Text] [Related]
13. Genetic analysis and natural history of Parkinson's disease due to the LRRK2 G2019S variant. Kmiecik MJ; Micheletti S; Coker D; Heilbron K; Shi J; Stagaman K; Filshtein Sonmez T; Fontanillas P; Shringarpure S; Wetzel M; Rowbotham HM; Cannon P; Shelton JF; Hinds DA; Tung JY; ; Holmes MV; Aslibekyan S; Norcliffe-Kaufmann L Brain; 2024 Jun; 147(6):1996-2008. PubMed ID: 38804604 [TBL] [Abstract][Full Text] [Related]
14. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Alcalay RN; Mirelman A; Saunders-Pullman R; Tang MX; Mejia Santana H; Raymond D; Roos E; Orbe-Reilly M; Gurevich T; Bar Shira A; Gana Weisz M; Yasinovsky K; Zalis M; Thaler A; Deik A; Barrett MJ; Cabassa J; Groves M; Hunt AL; Lubarr N; San Luciano M; Miravite J; Palmese C; Sachdev R; Sarva H; Severt L; Shanker V; Swan MC; Soto-Valencia J; Johannes B; Ortega R; Fahn S; Cote L; Waters C; Mazzoni P; Ford B; Louis E; Levy O; Rosado L; Ruiz D; Dorovski T; Pauciulo M; Nichols W; Orr-Urtreger A; Ozelius L; Clark L; Giladi N; Bressman S; Marder KS Mov Disord; 2013 Dec; 28(14):1966-71. PubMed ID: 24243757 [TBL] [Abstract][Full Text] [Related]
15. Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease. Gaig C; Vilas D; Infante J; Sierra M; García-Gorostiaga I; Buongiorno M; Ezquerra M; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E PLoS One; 2014; 9(10):e108982. PubMed ID: 25330404 [TBL] [Abstract][Full Text] [Related]
16. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene. Somme JH; Molano Salazar A; Gonzalez A; Tijero B; Berganzo K; Lezcano E; Fernandez Martinez M; Zarranz JJ; Gómez-Esteban JC Parkinsonism Relat Disord; 2015 May; 21(5):494-9. PubMed ID: 25840672 [TBL] [Abstract][Full Text] [Related]
17. LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic. Ben Romdhan S; Farhat N; Nasri A; Lesage S; Hdiji O; Ben Djebara M; Landoulsi Z; Stevanin G; Brice A; Damak M; Gouider R; Mhiri C Acta Neurol Scand; 2018 Nov; 138(5):425-431. PubMed ID: 29989150 [TBL] [Abstract][Full Text] [Related]
18. Associations of striatal dopamine transporter binding with motor and non-motor symptoms in early Parkinson's disease. Yang Z; Xie Y; Dou K; Yang L; Xie A Clin Transl Sci; 2023 Jun; 16(6):1021-1038. PubMed ID: 36915231 [TBL] [Abstract][Full Text] [Related]
19. Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Pachi I; Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Stamelou M; Trapali XG; Papageorgiou SG; Stefanis L Parkinsonism Relat Disord; 2021 Oct; 91():1-8. PubMed ID: 34425330 [TBL] [Abstract][Full Text] [Related]
20. Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation. Mirelman A; Heman T; Yasinovsky K; Thaler A; Gurevich T; Marder K; Bressman S; Bar-Shira A; Orr-Urtreger A; Giladi N; Hausdorff JM; Mov Disord; 2013 Oct; 28(12):1683-90. PubMed ID: 24123150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]